Literature DB >> 17965644

Radioactive iodine therapy in poorly differentiated thyroid cancer.

R Michael Tuttle1, Ravinder K Grewal, Steve M Larson.   

Abstract

BACKGROUND: A 55-year-old male was diagnosed with poorly differentiated thyroid cancer after total thyroidectomy, which was performed because of progressive enlargement of a dominant thyroid nodule. He developed an early cervical recurrence that was treated with modified neck dissection. He subsequently developed biopsy-proven progressive pulmonary metastases. INVESTIGATIONS: Neck and chest CT scans, laboratory tests, CT-guided fine-needle aspiration biopsy, [18F]-2-fluoro-2-deoxy-D-glucose-PET scan, lesional dosimetry using 124I PET scan, diagnostic radioactive iodine (RAI) scanning, whole-body and blood RAI dosimetry, and single-photon-emission CT. DIAGNOSIS: Stage IV poorly differentiated thyroid cancer. MANAGEMENT: Surgical resection of cervical recurrence, RAI therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17965644     DOI: 10.1038/ncponc0979

Source DB:  PubMed          Journal:  Nat Clin Pract Oncol        ISSN: 1743-4254


  6 in total

Review 1.  Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Gary L Francis; Steven G Waguespack; Andrew J Bauer; Peter Angelos; Salvatore Benvenga; Janete M Cerutti; Catherine A Dinauer; Jill Hamilton; Ian D Hay; Markus Luster; Marguerite T Parisi; Marianna Rachmiel; Geoffrey B Thompson; Shunichi Yamashita
Journal:  Thyroid       Date:  2015-07       Impact factor: 6.568

2.  Controversies and challenges in the management of well-differentiated thyroid cancer.

Authors:  N Gopalakrishna Iyer; Ashok R Shaha
Journal:  Indian J Surg       Date:  2010-01-13       Impact factor: 0.656

3.  Undetectable Thyroglobulin Levels in Poorly Differentiated Thyroid Carcinoma Patients Free of Macroscopic Disease After Initial Treatment: Are They Useful?

Authors:  Tihana Ibrahimpasic; Ronald Ghossein; Diane L Carlson; Iain J Nixon; Frank L Palmer; Snehal G Patel; Robert M Tuttle; Ashok Shaha; Jatin P Shah; Ian Ganly
Journal:  Ann Surg Oncol       Date:  2015-04-17       Impact factor: 5.344

4.  Potential anti-cancer effect of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a novel histone deacetylase inhibitor, for the treatment of thyroid cancer.

Authors:  Seok-Mo Kim; Ki-Cheong Park; Jeong-Yong Jeon; Bup-Woo Kim; Hyeung-Kyoo Kim; Ho-Jin Chang; Seung-Hoon Choi; Cheong-Soo Park; Hang-Seok Chang
Journal:  BMC Cancer       Date:  2015-12-23       Impact factor: 4.430

5.  I-131 uptake in fat necrosis of the breast.

Authors:  Malak Itani; David H Lewis
Journal:  Radiol Case Rep       Date:  2016-11-23

6.  Postoperative radioiodine therapy impact on survival in poorly differentiated thyroid carcinoma: a population-based study.

Authors:  Lei Xu; Qiong Zou; Ju Jiao; Yong Zhang
Journal:  Nucl Med Commun       Date:  2022-02-01       Impact factor: 1.690

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.